“…However, ICD-467 was ineffective in reactivating AChE in the brain and was found to be toxic (Shih, 1993;Harris et al, 1990). Imidazolium oximes can reactivate tabun-inhibited AChE (an adduct which contains a P-N bond instead of a P-O bond), and some can reactivate both tabun-inhibited and somaninhibited AChE (RS150D, 70% reactivation of GA; Im2-2, 44% reactivation of GA; Im2-13, 20% reactivation of GA and 71% reactivation of GD; Kovarik et al, 2013;Reiner & Simeon-Rudolf, 2006;Primožič et al, 2004). None have been superior to the bispyridinium oximes in reactivating tabuninhibited AChE (TMB-4, 91% reactivation of GA; obidoxime, 88% reactivation of GA; Worek et al, 2012); however, TMB-4 is ineffective against GD (Inns & Leadbeater, 1983) and obidoxime is also a poor reactivator of GD-inhibited AChE (Worek et al, 1998).…”